Entropy-Driven Nucleic Acid Amplifier Based on Spatial Confinement as a "Booster" for Detection of Extracellular Vesicle MicroRNAs to Diagnose Gastric Cancer and Monitor Therapeutic Response.
1/5 보강
Gastric cancer (GC) continues to pose a significant global health burden with persistent diagnostic challenges, especially in the detection of early-stage GC.
APA
Xia Y, Li B, et al. (2025). Entropy-Driven Nucleic Acid Amplifier Based on Spatial Confinement as a "Booster" for Detection of Extracellular Vesicle MicroRNAs to Diagnose Gastric Cancer and Monitor Therapeutic Response.. Analytical chemistry, 97(46), 25782-25796. https://doi.org/10.1021/acs.analchem.5c05375
MLA
Xia Y, et al.. "Entropy-Driven Nucleic Acid Amplifier Based on Spatial Confinement as a "Booster" for Detection of Extracellular Vesicle MicroRNAs to Diagnose Gastric Cancer and Monitor Therapeutic Response.." Analytical chemistry, vol. 97, no. 46, 2025, pp. 25782-25796.
PMID
41182092 ↗
Abstract 한글 요약
Gastric cancer (GC) continues to pose a significant global health burden with persistent diagnostic challenges, especially in the detection of early-stage GC. Herein, a strand displacement reaction-mediated nucleic acid amplifier based on the spatial confinement (SC-SDR) effect as a "booster" is constructed to detect extracellular vesicle-derived microRNAs (EVs-miRNAs). Constraining the reactant and fuel strands in a limited space using a T-shaped DNA structure results in a significant improvement in the reaction kinetics and sensitivity because of the high local strand concentrations, ultimately enabling the detection of EVs-miRNAs at the femtomolar level. SC-SDR is conjugated onto a hydrophobic tether to aid delivery into EVs, allowing for the detection of EVs-miRNAs. Four EVs-miRNAs act as biomarkers in combination with a random forest (RF) algorithm for use in GC diagnostics, prognostics, and early warning. In a cohort of 58 patients with GC, this diagnostic model effectively identifies 51 of the 58 cases, showing a satisfactory accuracy of 87.93%. This diagnostic efficiency outperforms that of conventional biomarkers (CEA and CA19-9), which exhibit accuracies of only 25.86% (15/58) and 17.24% (10/58), respectively. The longitudinal analysis of EVs-miRNA expression in GC patients before and after surgery and in patients with gastric intraepithelial neoplasia (GIN) reveals the dual utility of this approach as both a robust prognostic biomarker for GC progression and a promising predictive marker for GIN development. Overall, this study highlights the combined power of SC-SDR and machine learning for the analysis of EVs-miRNAs, paving the way for the clinical diagnosis and prognostication of GC.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- An inflammation-integrated prognostic nomogram for advanced-stage extranodal NK/T-cell lymphoma: a multicenter retrospective study.
- A Dual Glutathione-Depleting Nanoparticle Loaded with Porcine Pancreatic Elastase for Neoadjuvant Chemotherapy of Triple Negative Breast Cancer.
- A Retrospective Study on the Clinical Characteristics and Management of Immune-Related Adverse Events in Gynecologic Cancer Patients Treated with Immune Checkpoint Inhibitors.
- A single-center retrospective study suggests a potential benefit of BTK inhibitor-based therapy in patients with histologic transformation of Waldenström macroglobulinemia.
- Impact of Body Mass Index on Outcomes in Robotic Gastric Cancer Surgery.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.